Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex… Source: BioSpace You Might Also Like Cambridge-Based Biotech Scoops Up $46.7 Million in Funding Round October 4, 2017 Alcresta Snags FDA 510(K) Clearance for Use Of Relizorb in Kids July 19, 2017 Warning: These Could be the Top 3 Most Overrated Biotech Stocks June 18, 2017
